A double-blind randomized study to determine the effect of empagliflozin versus placebo on brain insulin sensitivity in patients with prediabetes

Mise à jour : Il y a 4 ans
Référence : EUCTR2016-003477-18

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

Key objective: to assess the effect of treatment with 25 mg empagliflozin daily versus placebo on regional brain insulin sensitivity. Effect of 8 weeks treatment with 25 mg empagliflozin or placebo on regional brain insulin sensitivity assessed by functional magnetic resonance imaging as change in regional cerebral blood flow from before to 30 minutes after nasal insulin spray application.


Critère d'inclusion

  • brain insulin sensitivity in patients with prediabetes

Liens